Validation of differential GDAP1 DNA methylation in alcohol dependence and its potential function as a biomarker for disease severity and therapy outcome

Epigenetics

Volumn 11, Issue 6, 2016, Pages 456-463

  Brückmann, Christof ^a   Di Santo, Adriana ^a   Karle, Kathrin Nora ^a   Batra, Anil ^a   Nieratschker, Vanessa ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Alcohol dependence; biomarker; disease severity; DNA methylation; epigenetics; GDAP1; replication; treatment outcome; validation

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA METHYLATION; EPIGENETICS; GDAP1 GENE; GENE; GENE AMPLIFICATION; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; BLOOD; CASE CONTROL STUDY; GENETIC EPIGENESIS; GENETICS; TREATMENT OUTCOME; VALIDATION STUDY;

BIOLOGICAL MARKER; GDAP PROTEIN; NERVE PROTEIN;

ADULT; ALCOHOLISM; BIOMARKERS; CASE-CONTROL STUDIES; DNA METHYLATION; EPIGENESIS, GENETIC; HUMANS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; TREATMENT OUTCOME;

EID: 84973109329     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.1080/15592294.2016.1179411     Document Type: Article

References (63)

1. A.Agrawal, M.T.Lynskey. Are there genetic influences on addiction: evidence from family, adoption and twin studies. Addiction 2008; 103:1069-81; PMID:18494843; http://dx.doi.org/10.1111/j.1360-0443.2008.02213.x
2. A.C.Heath, K.K.Bucholz, P.A.Madden, S.H.Dinwiddie, W.S.Slutske, L.J.Bierut, D.J.Statham, M.P.Dunne, J.B.Whitfield, N.G.Martin. Genetic and environmental contributions to alcohol dependence risk in a national twin sample: consistency of findings in women and men. Psychological Med 1997; 27:1381-96; PMID:9403910; http://dx.doi.org/10.1017/S0033291797005643
3. A.Agrawal, M.T.Lynskey, A.A.Todorov, A.J.Schrage, A.K.Littlefield, J.D.Grant, Q.Zhu, E.C.Nelson, P.A.Madden, K.K.Bucholz, et al. A candidate gene association study of alcohol consumption in young women. Alcohol Clin Exp Res 2011; 35:550-8; PMID:21143251; http://dx.doi.org/10.1111/j.1530-0277.2010.01372.x
4. M.Laucht, J.Treutlein, B.Schmid, D.Blomeyer, K.Becker, A.F.Buchmann, M.H.Schmidt, G.Esser, C.Jennen-Steinmetz, M.Rietschel, et al. Impact of psychosocial adversity on alcohol intake in young adults: moderation by the LL genotype of the serotonin transporter polymorphism. Biological psychiatry 2009; 66:102-9; PMID:19358979; http://dx.doi.org/10.1016/j.biopsych.2009.02.010
5. E.C.Nelson, A.Agrawal, M.L.Pergadia, J.C.Wang, J.B.Whitfield, F.S.Saccone, J.Kern, J.D.Grant, A.J.Schrage, J.P.Rice, et al. H2 haplotype at chromosome 17q21.31 protects against childhood sexual abuse-associated risk for alcohol consumption and dependence. Addict Biol 2010; 15:1-11; PMID:19878140; http://dx.doi.org/10.1111/j.1369-1600.2009.00181.x
6. D.Blomeyer, J.Treutlein, G.Esser, M.H.Schmidt, G.Schumann, M.Laucht. Interaction between CRHR1 gene and stressful life events predicts adolescent heavy alcohol use. Biological psychiatry 2008; 63:146-51; PMID:17597588; http://dx.doi.org/10.1016/j.biopsych.2007.04.026
7. V.Nieratschker, A.Batra, A.J.Fallgatter. Genetics and epigenetics of alcohol dependence. J Mol Psychiatry 2013; 1:11; PMID:25408904; http://dx.doi.org/10.1186/2049-9256-1-11
8. J.E.Sutherland, M.Costa. Epigenetics and the environment. Ann N Y Acad Sci 2003; 983:151-60.
9. H.Hashimoto, P.M.Vertino, X.Cheng. Molecular coupling of DNA methylation and histone methylation. Epigenomics 2010; 2:657-69; PMID:21339843; http://dx.doi.org/10.2217/epi.10.44
10. R.Holliday. DNA methylation and epigenetic mechanisms. Cell biophysics 1989; 15:15-20; PMID:2476223; http://dx.doi.org/10.1007/BF02991575
11. Y.Wang, F.C.Leung. An evaluation of new criteria for CpG islands in the human genome as gene markers. Bioinformatics 2004; 20:1170-7; PMID:14764558; http://dx.doi.org/10.1093/bioinformatics/bth059
12. G.Egger, G.Liang, A.Aparicio, P.A.Jones. Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004; 429:457-63; PMID:15164071; http://dx.doi.org/10.1038/nature02625
13. W.Doerfler. DNA methylation and gene activity. Ann Rev Biochem 1983; 52:93-124; PMID:6311083; http://dx.doi.org/10.1146/annurev.bi.52.070183.000521
14. P.A.Jones. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 2012; 13:484-92; PMID:22641018; http://dx.doi.org/10.1038/nrg3230
15. R.Feil, M.F.Fraga. Epigenetics and the environment: emerging patterns and implications. Nat Rev Genet 2011; 13:97-109; PMID: 22215131; http://dx.doi.org/10.1038/nrg3142
16. J.Mill, B.T.Heijmans. From promises to practical strategies in epigenetic epidemiology. Nat Rev Genet 2013; 14:585-94; PMID:23817309; http://dx.doi.org/10.1038/nrg3405
17. V.Januar, R.Saffery, J.Ryan. Epigenetics and depressive disorders: a review of current progress and future directions. Int J Epidemiol 2015; 44 (4):1364-1387; PMID:25716985; http://dx.doi.org/10.1093/ije/dyu273
18. H.M.Abdolmaleky, C.L.Smith, J.R.Zhou, S.Thiagalingam. Epigenetic alterations of the dopaminergic system in major psychiatric disorders. Methods Mol Biol 2008; 448:187-212; PMID:18370235; http://dx.doi.org/10.1007/978-1-59745-205-2_9
19. M.D.Plazas-Mayorca, K.E.Vrana. Proteomic investigation of epigenetics in neuropsychiatric disorders: a missing link between genetics and behavior? J Proteome Res 2011; 10:58-65; PMID:20735116; http://dx.doi.org/10.1021/pr100463y
20. S.Bleich, D.Degner, K.Javaheripour, C.Kurth, J.Kornhuber. Homocysteine and alcoholism. J Neural Transm Suppl 2000:187-96; PMID:11205139; http://dx.doi.org/10.1007/978-3-7091-6301-6_12
21. S.Bleich, D.Degner, J.Wiltfang, J.M.Maler, P.Niedmann, S.Cohrs, A.Mangholz, J.Porzig, R.Sprung, E.Ruther, et al. Elevated homocysteine levels in alcohol withdrawal. Alcohol and alcoholism 2000; 35:351-4; PMID:10905999; http://dx.doi.org/10.1093/alcalc/35.4.351
22. P.Heese, M.Linnebank, A.Semmler, M.A.Muschler, A.Heberlein, H.Frieling, B.Stoffel-Wagner, J.Kornhuber, M.Banger, S.Bleich, et al. Alterations of homocysteine serum levels during alcohol withdrawal are influenced by folate and riboflavin: results from the German Investigation on Neurobiology in Alcoholism (GINA). Alcohol and alcoholism 2012; 47:497-500; PMID:22645037; http://dx.doi.org/10.1093/alcalc/ags058
23. S.Bleich, T.Hillemacher. Homocysteine, alcoholism and its molecular networks. Pharmacopsychiatry 2009; 42 Suppl 1:S102-9; PMID:19434547; http://dx.doi.org/10.1055/s-0029-1214396
24. D.Bonsch, B.Lenz, U.Reulbach, J.Kornhuber, S.Bleich. Homocysteine associated genomic DNA hypermethylation in patients with chronic alcoholism. J Neural Transm 2004; 111:1611-6; PMID:15565495; http://dx.doi.org/10.1007/s00702-004-0232-x
25. S.W.French. Epigenetic events in liver cancer resulting from alcoholic liver disease. Alcohol Res 2013; 35:57-67; PMID:24313165
26. M.Varela-Rey, A.Woodhoo, M.L.Martinez-Chantar, J.M.Mato, S.C.Lu. Alcohol, DNA methylation, and cancer. Alcohol Res 2013; 35:25-35; PMID:24313162
27. R.A.Philibert, T.D.Gunter, S.R.Beach, G.H.Brody, A.Madan. MAOA methylation is associated with nicotine and alcohol dependence in women. Am J Med Genet B Neuropsychiatr Genet 2008; 147B:565-70; PMID:18454435; http://dx.doi.org/10.1002/ajmg.b.30778
28. V.Nieratschker, M.Grosshans, J.Frank, J.Strohmaier, C.von der Goltz, O.El-Maarri, S.H.Witt, S.Cichon, M.M.Nothen, F.Kiefer, et al. Epigenetic alteration of the dopamine transporter gene in alcohol-dependent patients is associated with age. Addiction biology 2014; 19:305-11; PMID:22506971; http://dx.doi.org/10.1111/j.1369-1600.2012.00459.x
29. R.A.Philibert, H.Sandhu, N.Hollenbeck, T.Gunter, W.Adams, A.Madan. The relationship of 5HTT (SLC6A4) methylation and genotype on mRNA expression and liability to major depression and alcohol dependence in subjects from the Iowa Adoption Studies. Am J Med Genet B Neuropsychiatr Genet 2008; 147B:543-9; PMID:17987668; http://dx.doi.org/10.1002/ajmg.b.30657
30. A.Heberlein, M.Muschler, H.Frieling, M.Behr, C.Eberlein, J.Wilhelm, M.Groschl, J.Kornhuber, S.Bleich, T.Hillemacher. Epigenetic down regulation of nerve growth factor during alcohol withdrawal. Addiction biology 2013; 18:508-10; PMID:21392176; http://dx.doi.org/10.1111/j.1369-1600.2010.00307.x
31. T.Hillemacher, C.Weinland, B.Lenz, T.Kraus, A.Heberlein, A.Glahn, M.A.Muschler, S.Bleich, J.Kornhuber, H.Frieling. DNA methylation of the LEP gene is associated with craving during alcohol withdrawal. Psychoneuroendocrinology 2015; 51:371-7; PMID:25462909; http://dx.doi.org/10.1016/j.psyneuen.2014.10.014
32. R.A.Philibert, B.Penaluna, T.White, S.Shires, T.Gunter, J.Liesveld, C.Erwin, N.Hollenbeck, T.Osborn. A pilot examination of the genome-wide DNA methylation signatures of subjects entering and exiting short-term alcohol dependence treatment programs. Epigenetics 2014; 9:1212-9; PMID:25147915; http://dx.doi.org/10.4161/epi.32252
33. B.Ruggeri, C.Nymberg, E.Vuoksimaa, A.Lourdusamy, C.P.Wong, F.M.Carvalho, T.Jia, A.Cattrell, C.Macare, T.Banaschewski, et al. Association of Protein Phosphatase PPM1G With Alcohol Use sDisorder and Brain Activity During Behavioral Control in a Genome-Wide Methylation Analysis. Am J Psychiatry 2015; 172:543-52; PMID:25982659; http://dx.doi.org/10.1176/appi.ajp.2014.14030382
34. R.Zhang, Q.Miao, C.Wang, R.Zhao, W.Li, C.N.Haile, W.Hao, X.Y.Zhang. Genome-wide DNA methylation analysis in alcohol dependence. Addiction biology 2013; 18:392-403; PMID:23387924; http://dx.doi.org/10.1111/adb.12037
35. S.L.Clark, K.A.Aberg, S.Nerella, G.Kumar, J.L.McClay, W.Chen, L.Y.Xie, A.Harada, A.A.Shabalin, G.Gao, et al. Combined Whole Methylome and Genomewide Association Study Implicates CNTN4 in Alcohol Use. Alcohol Clin Exp Res 2015; 39:1396-405; PMID:26146898; http://dx.doi.org/10.1111/acer.12790
36. B.Hultberg, M.Berglund, A.Andersson, A.Frank. Elevated plasma homocysteine in alcoholics. Alcohol Clin Exp Res 1993; 17:687-9; PMID:8392819; http://dx.doi.org/10.1111/j.1530-0277.1993.tb00820.x
37. D.Wedekind, K.Neumann, P.Falkai, B.Malchow, K.R.Engel, K.Jamrozinski, U.Havemann-Reinecke. S100B and homocysteine in the acute alcohol withdrawal syndrome. Eur Arch Psychiatry Clin Neurosci 2011; 261:133-8; PMID:20593192; http://dx.doi.org/10.1007/s00406-010-0121-2
38. T.Biermann, U.Reulbach, B.Lenz, H.Frieling, M.Muschler, T.Hillemacher, J.Kornhuber, S.Bleich. N-methyl-D-aspartate 2b receptor subtype (NR2B) promoter methylation in patients during alcohol withdrawal. J Neural Transm (Vienna) 2009; 116:615-22; PMID:19350219; http://dx.doi.org/10.1007/s00702-009-0212-2
39. M.Barneo-Munoz, P.Juarez, A.Civera-Tregon, L.Yndriago, D.Pla-Martin, J.Zenker, C.Cuevas-Martin, A.Estela, M.Sanchez-Arago, J.Forteza-Vila, et al. Lack of GDAP1 induces neuronal calcium and mitochondrial defects in a knockout mouse model of charcot-marie-tooth neuropathy. PLoS Genet 2015; 11:e1005115; PMID:25860513; http://dx.doi.org/10.1371/journal.pgen.1005115
40. M.Tazir, T.Hamadouche, S.Nouioua, S.Mathis, J.M.Vallat. Hereditary motor and sensory neuropathies or Charcot-Marie-Tooth diseases: an update. J Neurological Sci 2014; 347:14-22; PMID:25454638; http://dx.doi.org/10.1016/j.jns.2014.10.013
41. P.Yi, S.Melnyk, M.Pogribna, I.P.Pogribny, R.J.Hine, S.J.James. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem 2000; 275:29318-23; PMID:10884384; http://dx.doi.org/10.1074/jbc.M002725200
42. A.Semmler, P.Heese, B.Stoffel-Wagner, M.Muschler, A.Heberlein, L.Bigler, J.C.Prost, H.Frieling, J.Kornhuber, M.Banger, et al. Alcohol abuse and cigarette smoking are associated with global DNA hypermethylation: results from the German Investigation on Neurobiology in Alcoholism (GINA). Alcohol 2015; 49:97-101; PMID:25702197; http://dx.doi.org/10.1016/j.alcohol.2015.01.004
43. J.Roessler, O.Ammerpohl, J.Gutwein, B.Hasemeier, S.L.Anwar, H.Kreipe, U.Lehmann. Quantitative cross-validation and content analysis of the 450k DNA methylation array from Illumina, Inc. BMC Res Notes 2012; 5:210; PMID:22546179; http://dx.doi.org/10.1186/1756-0500-5-210
44. S.Dedeurwaerder, M.Defrance, M.Bizet, E.Calonne, G.Bontempi, F.Fuks. A comprehensive overview of Infinium HumanMethylation450 data processing. Brief Bioinform 2014; 15:929-41; PMID:23990268; http://dx.doi.org/10.1093/bib/bbt054
45. M.V.Dogan, B.Shields, C.Cutrona, L.Gao, F.X.Gibbons, R.Simons, M.Monick, G.H.Brody, K.Tan, S.R.Beach, et al. The effect of smoking on DNA methylation of peripheral blood mononuclear cells from African American women. BMC Genom 2014; 15:151; PMID:24559495; http://dx.doi.org/10.1186/1471-2164-15-151
46. K.M.Krajewski, R.A.Lewis, D.R.Fuerst, C.Turansky, S.R.Hinderer, J.Garbern, J.Kamholz, M.E.Shy. Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. Brain 2000; 123 (Pt 7):1516-27; PMID:10869062; http://dx.doi.org/10.1093/brain/123.7.1516
47. M.M.Watila, S.A.Balarabe. Molecular and clinical features of inherited neuropathies due to PMP22 duplication. J Neurological Sci 2015; 355:18-24; PMID:26076881; http://dx.doi.org/10.1016/j.jns.2015.05.037
48. R.Cartoni, J.C.Martinou. Role of mitofusin 2 mutations in the physiopathology of Charcot-Marie-Tooth disease type 2A. Exp Neurol 2009; 218:268-73; PMID:19427854; http://dx.doi.org/10.1016/j.expneurol.2009.05.003
49. D.Kabzinska, K.Kotruchow, J.Cegielska, I.Hausmanowa-Petrusewicz, A.Kochanski. A severe recessive and a mild dominant form of Charcot-Marie-Tooth disease associated with a newly identified Glu222Lys GDAP1 gene mutation. Acta biochimica Polonica 2014; 61:739-44; PMID:25337607
50. A.Niemann, K.M.Wagner, M.Ruegg, U.Suter. GDAP1 mutations differ in their effects on mitochondrial dynamics and apoptosis depending on the mode of inheritance. Neurobiol Dis 2009; 36:509-20; PMID:19782751; http://dx.doi.org/10.1016/j.nbd.2009.09.011
51. R.Noack, S.Frede, P.Albrecht, N.Henke, A.Pfeiffer, K.Knoll, T.Dehmel, G.Meyer Zu Horste, M.Stettner, B.C.Kieseier, et al. Charcot-Marie-Tooth disease CMT4A: GDAP1 increases cellular glutathione and the mitochondrial membrane potential. Hum Mol Genet 2012; 21:150-62; PMID:21965300; http://dx.doi.org/10.1093/hmg/ddr450
52. E.Gonzalez-Reimers, F.Santolaria-Fernandez, M.C.Martin-Gonzalez, C.M.Fernandez-Rodriguez, G.Quintero-Platt. Alcoholism: a systemic proinflammatory condition. World J Gastroenterol 2014; 20:14660-71; PMID:25356029; http://dx.doi.org/10.3748/wjg.v20.i40.14660
53. I.Chumakov, A.Milet, N.Cholet, G.Primas, A.Boucard, Y.Pereira, E.Graudens, J.Mandel, J.Laffaire, J.Foucquier, et al. Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy. Orphanet J Rare Dis 2014; 9:201; PMID:25491744; http://dx.doi.org/10.1186/s13023-014-0201-x
54. S.Attarian, J.M.Vallat, L.Magy, B.Funalot, P.M.Gonnaud, A.Lacour, Y.Pereon, O.Dubourg, J.Pouget, J.Micallef, et al. An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A. Orphanet J Rare Dis 2014; 9:199; PMID:25519680; http://dx.doi.org/10.1186/s13023-014-0199-0
55. P.Crowley. Long-term drug treatment of patients with alcohol dependence. Australian Prescriber 2015; 38:41-3; PMID:26648614; http://dx.doi.org/10.18773/austprescr.2015.015
56. M.Soyka, J.Mutschler. Treatment-refractory substance use disorder: Focus on alcohol, opioids, and cocaine. Prog Neuro-psychopharmacol Biol Psychiatry 2015; PMID:26577297; http://dx.doi.org/10.1016/j.pnpbp.2015.11.003
57. M.Ratajewski, L.Pulaski. YY1-dependent transcriptional regulation of the human GDAP1 gene. Genomics 2009; 94:407-13; PMID:19720140; http://dx.doi.org/10.1016/j.ygeno.2009.08.014
58. A.Mathelier, O.Fornes, D.J.Arenillas, C.Y.Chen, G.Denay, J.Lee, W.Shi, C.Shyr, G.Tan, R.Worsley-Hunt, et al. JASPAR 2016: a major expansion and update of the open-access database of transcription factor binding profiles. Nucleic Acids Res 2016; 44:D110-5; PMID:26531826; http://dx.doi.org/10.1093/nar/gkv1176
59. T.M.Donohue, Jr., N.A.Osna, C.S.Trambly, N.P.Whitaker, P.G.Thomes, S.L.Todero, J.S.Davis. Early growth response-1 contributes to steatosis development after acute ethanol administration. Alcoholism Clin Exp Res 2012; 36:759-67; PMID:22141421; http://dx.doi.org/10.1111/j.1530-0277.2011.01681.x
60. O.A.Barski, V.Z.Papusha, G.R.Kunkel, K.H.Gabbay. Regulation of aldehyde reductase expression by STAF and CHOP. Genomics 2004; 83:119-29; PMID:14667815; http://dx.doi.org/10.1016/S0888-7543(03)00213-1
61. J.B.Saunders, O.G.Aasland, T.F.Babor, J.R.de la Fuente, M.Grant. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption–II. Addiction 1993; 88:791-804; PMID:8329970; http://dx.doi.org/10.1111/j.1360-0443.1993.tb02093.x
62. D.H.Moak, R.F.Anton, P.K.Latham. Further validation of the Obsessive-Compulsive Drinking Scale (OCDS). Relationship to alcoholism severity. Am J Addict 1998; 7:14-23; PMID:9522003; http://dx.doi.org/10.1111/j.1521-0391.1998.tb00463.x
63. C.Mercier, S.Brochu, M.Girard, J.Gravel, R.Ouellet, R.Pare. Profiles of alcoholics according to the SCL-90-R: a confirmative study. Int J Addict 1992; 27:1267-82; PMID:1446961; http://dx.doi.org/10.3109/10826089209047349